In early-stage breast cancer, ctDNA analysis is difficult due to the lower ctDNA concentration compared with metastatic disease and differences in the rate of ctDNA shedding based on the type of BC; luminal BC shedding has lower levels compared with HER2 + BC and TNBC. This evidence concerns the gene ERBB2 and breast carcinoma.